About STE20-related kinase adapter protein beta
STE20-related kinase adapter protein beta (STRADB) is a protein
from Homo sapiens identified by UniProt accession
Q9C0K7, 418 residues long.
MolForge cross-references it against 0 known binders and
40 disease associations.
Target properties
| Protein name | STE20-related kinase adapter protein beta |
| UniProt accession | Q9C0K7 |
| Gene | STRADB |
| Organism | Homo sapiens |
| Length | 418 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (40)
Diseases linked to this target (Open Targets).
- mean corpuscular hemoglobin concentration · score 0.30
- breast adenocarcinoma · score 0.28
- lung adenocarcinoma · score 0.26
- mean corpuscular hemoglobin · score 0.24
- breast carcinoma · score 0.21
- body height · score 0.18
- serum gamma-glutamyl transferase measurement · score 0.14
- clear cell renal carcinoma · score 0.11
- triglyceride measurement · score 0.09
- reticulocyte measurement · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9C0K7-F1 | alphafold | PREDICTED | 74.30 | — |
Amino-acid sequence (418 residues)
MSLLDCFCTS RTQVESLRPE KQSETSIHQY LVDEPTLSWS RPSTRASEVL CSTNVSHYEL QVEIGRGFDN LTSVHLARHT PTGTLVTIKI TNLENCNEER LKALQKAVIL SHFFRHPNIT TYWTVFTVGS WLWVISPFMA YGSASQLLRT YFPEGMSETL IRNILFGAVR GLNYLHQNGC IHRSIKASHI LISGDGLVTL SGLSHLHSLV KHGQRHRAVY DFPQFSTSVQ PWLSPELLRQ DLHGYNVKSD IYSVGITACE LASGQVPFQD MHRTQMLLQK LKGPPYSPLD ISIFPQSESR MKNSQSGVDS GIGESVLVSS GTHTVNSDRL HTPSSKTFSP AFFSLVQLCL QQDPEKRPSA SSLLSHVFFK QMKEESQDSI LSLLPPAYNK PSISLPPVLP WTEPECDFPD EKDSYWEF
Explore STE20-related kinase adapter protein beta with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets